NOW Stock Outlook 2026: ServiceNow's GenAI Revenue Machine and the Valuation Question
ServiceNow 2026 analysis: Now Assist GenAI ARPU expansion, cRPO visibility, ITSM/HRSD/ITOM platform moat, valuation risk, and how US investors should think about holding NOW.
NOW ServiceNow SaaS